Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07310758) titled 'Contrast-enhanced Ultrasound for Sentinel Node Detection' on Dec. 16, 2025.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: The Netherlands Cancer Institute
Condition:
Melanoma
Breast Cancer
Head & Neck Cancer
Intervention:
Drug: Sonazoid
Recruitment Status: Recruiting
Phase: Phase 2/Phase 3
Date of First Enrollment: September 18, 2025
Target Sample Size: 91
Countries of Recruitment:
Netherlands
To know more, visit https://clinicaltrials.gov/study/NCT07310758
Disclaimer: Cu...